CN102512525A - 治疗奶牛空怀不孕症的中药组合物及其制备方法和用途 - Google Patents
治疗奶牛空怀不孕症的中药组合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN102512525A CN102512525A CN201110417053XA CN201110417053A CN102512525A CN 102512525 A CN102512525 A CN 102512525A CN 201110417053X A CN201110417053X A CN 201110417053XA CN 201110417053 A CN201110417053 A CN 201110417053A CN 102512525 A CN102512525 A CN 102512525A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- component
- nonpregnant
- time
- infertility
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 125
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 208000000509 infertility Diseases 0.000 title claims abstract description 25
- 230000036512 infertility Effects 0.000 title claims abstract description 25
- 231100000535 infertility Toxicity 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 241000283690 Bos taurus Species 0.000 title abstract description 71
- 235000013365 dairy product Nutrition 0.000 title abstract description 7
- 210000000582 semen Anatomy 0.000 claims abstract description 38
- 229940079593 drug Drugs 0.000 claims abstract description 25
- 238000001035 drying Methods 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 44
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 31
- 239000002994 raw material Substances 0.000 claims description 26
- 229940042126 oral powder Drugs 0.000 claims description 25
- 238000000605 extraction Methods 0.000 claims description 24
- 238000002347 injection Methods 0.000 claims description 24
- 239000007924 injection Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000008213 purified water Substances 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 17
- 239000000796 flavoring agent Substances 0.000 claims description 15
- 235000019634 flavors Nutrition 0.000 claims description 14
- 238000007689 inspection Methods 0.000 claims description 13
- 241000411851 herbal medicine Species 0.000 claims description 12
- 238000012856 packing Methods 0.000 claims description 11
- 238000005303 weighing Methods 0.000 claims description 11
- 238000004458 analytical method Methods 0.000 claims description 8
- 235000008216 herbs Nutrition 0.000 claims description 8
- 230000004087 circulation Effects 0.000 claims description 7
- 238000005516 engineering process Methods 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000002137 ultrasound extraction Methods 0.000 claims description 6
- 239000006200 vaporizer Substances 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 241001446509 Psoralea Species 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 abstract description 36
- 239000008267 milk Substances 0.000 abstract description 36
- 210000004080 milk Anatomy 0.000 abstract description 36
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000006651 lactation Effects 0.000 abstract description 6
- 208000015124 ovarian disease Diseases 0.000 abstract description 4
- 230000009471 action Effects 0.000 abstract description 2
- 238000009395 breeding Methods 0.000 abstract description 2
- 230000001488 breeding effect Effects 0.000 abstract description 2
- 239000000470 constituent Substances 0.000 abstract 4
- 230000035935 pregnancy Effects 0.000 abstract 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 244000178320 Vaccaria pyramidata Species 0.000 abstract 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 238000009396 hybridization Methods 0.000 abstract 1
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 239000000047 product Substances 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 239000000583 progesterone congener Substances 0.000 description 9
- 102000003946 Prolactin Human genes 0.000 description 8
- 108010057464 Prolactin Proteins 0.000 description 8
- 239000005557 antagonist Substances 0.000 description 8
- 229940097325 prolactin Drugs 0.000 description 8
- 230000001983 lactogenic effect Effects 0.000 description 7
- 229940011871 estrogen Drugs 0.000 description 6
- 239000000262 estrogen Substances 0.000 description 6
- 238000010255 intramuscular injection Methods 0.000 description 6
- 239000007927 intramuscular injection Substances 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000001672 ovary Anatomy 0.000 description 6
- -1 Glycines glycoside Chemical class 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 210000005075 mammary gland Anatomy 0.000 description 4
- 206010062767 Hypophysitis Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000002267 hypothalamic effect Effects 0.000 description 3
- 210000003016 hypothalamus Anatomy 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 208000021267 infertility disease Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000002445 nipple Anatomy 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000004145 Endometritis Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010060710 Galactostasis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 102000009151 Luteinizing Hormone Human genes 0.000 description 2
- 108010073521 Luteinizing Hormone Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 210000004246 corpus luteum Anatomy 0.000 description 2
- ZZIALNLLNHEQPJ-UHFFFAOYSA-N coumestrol Chemical compound C1=C(O)C=CC2=C1OC(=O)C1=C2OC2=CC(O)=CC=C12 ZZIALNLLNHEQPJ-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 208000025661 ovarian cyst Diseases 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 230000001817 pituitary effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- IRZTUXPRIUZXMP-UHFFFAOYSA-N rubiadin Chemical compound C1=CC=C2C(=O)C3=C(O)C(C)=C(O)C=C3C(=O)C2=C1 IRZTUXPRIUZXMP-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 102000006771 Gonadotropins Human genes 0.000 description 1
- 108010086677 Gonadotropins Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010046793 Uterine inflammation Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- OAUREGNZECGNQS-UHFFFAOYSA-N corylifolin Natural products O1C=2C=C(O)C(CC=C(C)C)=CC=2C(=O)CC1C1=CC=C(O)C=C1 OAUREGNZECGNQS-UHFFFAOYSA-N 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229940028334 follicle stimulating hormone Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000002622 gonadotropin Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000003552 hormonogenic effect Effects 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical group C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000000009 lactational effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110417053 CN102512525B (zh) | 2011-12-14 | 2011-12-14 | 治疗奶牛空怀不孕症的中药组合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110417053 CN102512525B (zh) | 2011-12-14 | 2011-12-14 | 治疗奶牛空怀不孕症的中药组合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102512525A true CN102512525A (zh) | 2012-06-27 |
CN102512525B CN102512525B (zh) | 2013-11-06 |
Family
ID=46283778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110417053 Expired - Fee Related CN102512525B (zh) | 2011-12-14 | 2011-12-14 | 治疗奶牛空怀不孕症的中药组合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102512525B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103720993A (zh) * | 2013-11-15 | 2014-04-16 | 北安市飞龙动物药厂 | 一种提高母畜排卵质量的中药组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003037246A2 (en) * | 2001-07-17 | 2003-05-08 | Integrated Chinese Medicine Holdings Ltd. | Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
CN1733138A (zh) * | 2005-08-10 | 2006-02-15 | 范明国 | 一种治疗动物不孕症的药物 |
CN101342353A (zh) * | 2008-07-24 | 2009-01-14 | 王镇 | 治疗不孕症的中药制剂及其制备方法 |
CN101579430A (zh) * | 2008-05-13 | 2009-11-18 | 天津生机集团股份有限公司 | 治疗牛不孕症的中兽药灌注液及其制备方法 |
-
2011
- 2011-12-14 CN CN 201110417053 patent/CN102512525B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003037246A2 (en) * | 2001-07-17 | 2003-05-08 | Integrated Chinese Medicine Holdings Ltd. | Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
CN1733138A (zh) * | 2005-08-10 | 2006-02-15 | 范明国 | 一种治疗动物不孕症的药物 |
CN101579430A (zh) * | 2008-05-13 | 2009-11-18 | 天津生机集团股份有限公司 | 治疗牛不孕症的中兽药灌注液及其制备方法 |
CN101342353A (zh) * | 2008-07-24 | 2009-01-14 | 王镇 | 治疗不孕症的中药制剂及其制备方法 |
Non-Patent Citations (1)
Title |
---|
刘晓琳等: "中药的激素样作用研究", 《中兽医医药杂志》, no. 3, 31 December 2006 (2006-12-31) * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103720993A (zh) * | 2013-11-15 | 2014-04-16 | 北安市飞龙动物药厂 | 一种提高母畜排卵质量的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN102512525B (zh) | 2013-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105076893A (zh) | 一种奶牛饲料及其制备方法 | |
CN104706704A (zh) | 玛咖组合物、其复方制剂及其应用 | |
CN101138597B (zh) | 一种防治骨质疏松症的中药制剂及其制备方法 | |
KR101600751B1 (ko) | 녹용을 함유하는 여성 불임증 치료용 한약 조성물 제조 방법 | |
CN104800720A (zh) | 用于改善种公牛性欲提高精液产量的药物及制备方法 | |
CN102512525B (zh) | 治疗奶牛空怀不孕症的中药组合物及其制备方法和用途 | |
CN102218127B (zh) | 治疗痛经的中药组合物及其制备方法 | |
CN101804153B (zh) | 一种催乳中药颗粒剂 | |
CN104042774A (zh) | 一种治疗骨质疏松症的药物组合物 | |
KR102129595B1 (ko) | 복합 발효 하수오 추출물과 한약재 추출물을 이용한 갱년기 증상 개선용 음료의 제조방법 | |
CN111481614A (zh) | 无比山药丸在制备治疗围绝经期综合征药物中的应用 | |
KR101810421B1 (ko) | 아마씨를 포함하는 갱년기 증상 개선용 환의 제조방법 | |
KR20110089036A (ko) | 불임증 개선을 위한 기능성 식품조성물 | |
CN101632707A (zh) | 一种鹿胎膏及其制备方法 | |
CN107485665A (zh) | 用于抗卵巢早衰的中药组合物及其相关制剂 | |
CN106620066A (zh) | 一种用于家畜催情促孕的中药组合物及其制备方法 | |
CN106109830A (zh) | 一种预防和治疗月子病的中药组合物 | |
CN100998743A (zh) | 一种治疗妇女不孕不育症的中药组合物及其制备方法和应用 | |
CN107441313B (zh) | 治疗卵巢储备功能下降的中药组合物、药物及其制备方法 | |
CN106728645A (zh) | 一种家畜催乳的中药复方组合物 | |
CN114010705A (zh) | 用于治疗女性卵巢早衰的双合疗法制剂及其制备方法 | |
CN105250622A (zh) | 一种治疗内分泌失调的中药胶囊及其制备方法 | |
CN113633743A (zh) | 一种治疗宫外孕的中药组合物及其制备方法 | |
CN105709117A (zh) | 一种含有艾叶的治疗女性肾阳虚型排卵障碍的中药组合物 | |
CN104127635A (zh) | 一种用于补肾健肾的中草药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BEIAN FEILONG ANIMAL DRUGS FACTORY Free format text: FORMER OWNER: ZHAO XINGYOU Effective date: 20130520 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130520 Address after: 164000 Heilongjiang province Bei'an City Qinghua high tech Park Applicant after: BEI'AN FEILONG ANIMAL PHARMACEUTICAL FACTORY Address before: 164000 Heilongjiang province Bei'an City Qinghua high tech Park Applicant before: Zhao Xingyou |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131106 Termination date: 20171214 |